secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2023-03-22T23:59:59+00:00
Accession:  0001493152-23-008547
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa Pharmaceuticals receives Nasdaq deficiency notice for bid price below $1.00 per share
--------------------------------------------------------------------------------

- Received Notice on March 22, 2023 that common stock bid price closed below $1.00 for 30 consecutive business days.
- Granted 180 days, until September 18, 2023, to regain compliance by closing at $1.00+ for 10 consecutive business days.
- If not compliant by Compliance Date, may qualify for second 180-day period or face delisting with appeal rights.
- Stock continues to trade on Nasdaq Capital Market under symbol PCSA during this period.
- No assurance of regaining compliance; company monitoring bid price and will seek to comply.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315223008547/0001493152-23-008547-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315223008547/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-008547

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer